Wellness Franchise Opportunities

GSK Jul, 10 2017

GSK Pharma looks at enhancing global respiratory and vaccines pipeline

The factory will initially supply a range of solid dose form products. The factory will commence production in 2018 and produce more than 8 billion tablets and 1 billion capsules a year

By Franchise India Bureau
GSK Pharma looks at enhancing global respiratory and vaccines pipeline

Global healthcare company, GlaxoSmithKline Pharmaceuticals is investing Rs 1000 crore in a new state-of-the-art pharmaceutical unit in Karnataka and is looking at enhancing its global pipeline in areas like respiratory drugs and vaccines in India.

"We are investing Rs 1000 crore in a new state-of-the- art pharmaceutical factory in Vemgal, Karnataka. The factory will initially supply a range of solid dose form products. The factory will commence production in 2018 and produce more than 8 billion tablets and 1 billion capsules a year," the company said in its annual report.

A Vaidheesh, Managing Director, GSK India, said, "We will focus on securing reliable supply of our high- quality medicines to patients through our manufacturing facility in Nashik, Maharashtra and our upcoming facility in Vemgal, Karnataka. We will continue to bring the best of our innovative global pipeline in areas like respiratory and vaccines to our patients in India."

The company is assessing new products from its global respiratory and vaccines pipeline and reviewing these for a possible launch in India. In addition, it is also reviewing complementary inorganic opportunities, the company said.

Nearly 30 per cent of global pharmaceutical volumes sold by GSK is sold in the country.

The drug major is also upgrading its existing Nashik facility. In compliance with the GSK respiratory free strategy and the WHO requirement for the segregated manufacturing of hormonal products, GSK India has invested Rs 115 crore to construct a dedicated facility for the manufacturing of Eltroxin. The new eltroxin facility will be fully operational in 2018.

Related: Sensodyne teams up with airlines, Rajdhani trains to reach 1 million consumers

Click Here to add Comment
Please add your Comment
Rating
Sell Franchise 2017

Newsletter Signup

Submit your email address to receive the latest updates on news & host of opportunities from Wellness India.

Video

Magazines & Books

Read the latest franchising magazines and books to get comprehensive and up-to-date information on leading franchise systems, trends and more.


Newsletter Signup
Submit your email address to receive the latest updates on news & host of opportunities.
Well Ness India

Copyright © 2009 - 2017 Franchise India Holdings Ltd.

The information contained herein is of generic nature only, and Franchise India is not, by means of this website or any part thereof, rendering professional advice or services. Before making any decision or taking any action that might affect your finances or business, you should consult a qualified professional advisor. Your use of this website or any of its pages or links given, is at your own risk and you assume full responsibility and risk of loss resulting from your usage. With respect to use of the website, kindly visit www.franchiseindia.com/terms.